Glover Stephen C. 4
4 · ZyVersa Therapeutics, Inc. · Filed Jul 15, 2025
Insider Transaction Report
Form 4
Glover Stephen C.
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2025-07-11+136,900→ 136,900 totalExercise: $0.59Exp: 2035-07-11→ Common Stock (136,900 underlying)
Footnotes (1)
- [F1]The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.